98%
921
2 minutes
20
The corneal endothelial transplantation involves the transfer and attachment of a single-layered corneal endothelial tissue to the narrow space between the cornea and iris. Given the high risk of damage to the endothelial tissue and surrounding corneal tissues when using sharp instruments inserted externally to apply force during the process, the development of a device capable of transferring corneal endothelial tissue using a magnetic field became necessary. This study aims to develop a magnetic control device for transferring corneal endothelial tissue with attached magnetic particles to the transplant site, validate its appropriate transfer capabilities, and assess its applicability to corneal endothelial transplantation. For this purpose, a magnetic field-generating manipulation device equipped with four electromagnets controlled by a joystick and microcomputer was developed. Through simulated experiments, the strength of the magnetic field and the attraction force on the tissue were predicted, and the actual magnetic field strength was measured for validation. To measure the magnetic transfer force, experiments were conducted by towing corneal endothelial tissue fixed with 6 mg, 12 mg, and 18 mg plastic weights. Subsequently, the tissue's transfer speed was measured after applying continuous and pulsed magnetic fields. The results confirmed the feasibility of tissue transfer using the magnetic control device, and it was observed that pulsed magnetic fields led to faster transfer speeds and easier control compared to continuous magnetic fields. Exploratory animal experiments using rabbits were conducted to simulate real surgical conditions, confirming the feasibility of corneal endothelial tissue transfer and attachment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11208361 | PMC |
http://dx.doi.org/10.1007/s13534-024-00371-6 | DOI Listing |
Eye (Lond)
September 2025
Department of Innovative Visual Science, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Br J Ophthalmol
September 2025
Apgujeong St. Mary's Eye Center, Seoul, Korea (the Republic of).
Background/aims: In cytomegalovirus-induced anterior uveitis (CMV-AU), frequent recurrences are the primary cause of glaucomatous damage and corneal endothelial cell loss, yet factors influencing such recurrences remain unclear. Our study aims to investigate the impact of glaucoma surgery (GS) on recurrence rate in patients with CMV-AU.
Methods: This retrospective study included 149 immunocompetent patients with CMV-AU treated with antiviral medication following PCR confirmation.
J Cataract Refract Surg
July 2025
Department of Ophthalmology, Santo António Local Health Unit, Porto, Portugal.
Purpose: To demonstrate the efficacy and safety of iris-claw phakic intraocular lens (pIOL) in the treatment of post keratoplasty astigmatism.
Setting: Cornea Unit, Ophthalmology Department - Unidade Local de Saúde de Santo António - Porto, Portugal.
Design: Retrospective longitudinal study.
Exp Eye Res
September 2025
Cornea, Cataract and Refractive Surgery Unit, Vissum (Miranza Group), Alicante, Spain; Division of Ophthalmology, School of Medicine, Universidad Miguel Hernández, Alicante, Spain. Electronic address:
Corneal opacity remains a leading cause of global blindness, yet conventional corneal transplantation is constrained by donor scarcity, surgical limitations, and suboptimal long-term outcomes. In response, regenerative strategies are advancing to restore structural and functional integrity across all three corneal layers-epithelium, stroma, and endothelium-through cell-based and bioengineered therapies. Among these, induced pluripotent stem cells (iPSCs) have emerged as a versatile and scalable source capable of generating corneal-like cells under defined, xeno-free conditions.
View Article and Find Full Text PDFCornea
September 2025
Department of Ophthalmology, University of Duesseldorf, Duesseldorf, Germany.
Purpose: To report a case of late dehiscence of an EndoArt implant and its successful management 10 months after initial implantation.
Methods: Case report.
Results: A 73-year-old man with a history of multiple failed Descemet membrane endothelial keratoplasty procedures on the right eye underwent EndoArt implantation for bullous keratopathy.